Evaluation of Trends in Oncology Drug Spending in Medicare, 2016 to 2020

This cross-sectional study examines trends in drug spending in Medicare Parts B and D and describes the share of total use and spending attributed to oncology drugs within each program.

Detalles Bibliográficos
Autores principales: Kyle, Michael Anne, Dusetzina, Stacie B., Keating, Nancy L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280395/
https://www.ncbi.nlm.nih.gov/pubmed/35816318
http://dx.doi.org/10.1001/jamanetworkopen.2022.21468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9280395/
https://www.ncbi.nlm.nih.gov/pubmed/35816318
http://dx.doi.org/10.1001/jamanetworkopen.2022.21468

Ejemplares similares